The Decision Group has a top focus on healthcare. In cooperation with several academic institutes, we frequently perform research on the developments in healthcare in order to give our clients access to the latest international insights. Our expertise ranges from

  • Hospital or medical department strategy; to
  • Business model development for practice units; to
  • In-depth knowledge on developing hospital quality measures; to
  • Expertise in Time-driven Activity Based costing, a proven method to determine real cost; and
  • Action Learning Programs on change, translating theory into daily practice.

We have an internationally leading expertise on the development of patient relevant medical outcome measures. As official Partner of Prof. Michael Porter at Harvard Business School we have developed practical ways to implement his theory of ‘Value-Based Health Care’. In our projects and studies we work for and with all the various players in the Dutch healthcare system: healthcare providers, patient organizations, policy makers, and health insurers. The Decision Group  employs a unique implementation approach in which the focus is placed on results and organizational culture. We believe that costs in healthcare can be reduced by focusing first and foremost on improving quality of healthcare delivery.


  • Creating insight in patient value (registration of patient value in a scoped geographical area)
  • Defining the proper medical condition
  • Developing an internal steering model based on outcomes
  • Setting up a health costing model using time driven activity based costing (TDABC) (in cooperation with Prof. Bob Kaplan)
  • Organizing empowerment conferences; delivering insight, vision and inspiration to groups of professionals
  • Investigation of value-adding steps in the care delivery chain with the aim to increase efficiency and effectiveness, or clarify potential patient safety leaks
  • Retrieval of outcome measure data (datamanagement)
  • Building the value proposition for your patients
  • Learning how to be a better negotiator to insurers, boards, and other demanding parties
  • Support with making investment-, impact-, portfolio-decisions on diagnostics.
  • Advise on governance: board of trustees, performance, right culture, incentive scheme, patient safety.

The three methods we use, to transfer the knowledge and right directions, are workshops, in-house education and change/implementation programs.

  • Workshops: We provide insights in the best practices and latest international knowledge
  • Inhouse Programs: We show how we do it, so you can do it yourself
  • Projects: We will assist you in implementing the method through your organization

For more information, please contact us at 020-4040111, or send an email to


Meetbaar BeterMeasurably Better: is a scientifically based program using patient relevant medical outcome indicators in a physician-driven and patient-centered manner to improve quality and transparency of healthcare in the participating cardiac centers. For more information please visit

SanteonZorg voor Uitkomst: The Santeon hospitals have developed, with the help of The Desicion Group, so called “outcome measures” for the treatment of lung- and prostate cancer. What is the risk of complications, how long does the patient survive after treatment and what is the quality of life?
IN DUTCH: De Santeon ziekenhuizen hebben met hulp van The Decision Group zogenoemde ‘uitkomstindicatoren’ ontwikkeld voor behandeling van longkanker en prostaatkanker. Wat is het risico op complicaties, hoe lang leeft de patiënt na behandeling en wat is de kwaliteit van leven?


Famous: The goal of the FAMOUS project is to improve and optimize the process of diagnosis (the triage) around the patient.A collaboration between St. Antonius hospital, Isala, The Decision Group, RAVU, RAV Ijsselland and Meander Medical Center, UMC Utrecht and the Julius Center.
IN DUTCH: Het FAMOUS project heeft als doel het diagnostische proces (de triage) rondom (NSTEMI) patiënten te verbeteren en te optimaliseren. Een samenwerkingsverband tussen St. Antonius Ziekenhuis, Isala, The Decision Group, RAVU, RAV Ijsselland en Meander Medisch Centrum, UMC Utrecht en het Julius Centrum.

Hagazkh Excellent

Management Development Programma: The Decision Group, De Excellente Maatschap en the HagaZiekenhuis (HagaHospital) have developed a program for the medical managers of the hospital. This program has two points of focus: implementing Value-Based Health Care through a.o. Harvard Business School Cases and the incentives-methodology of Management Drives based on the theory of dr. Clarence Graves.
IN DUTCH: The Decision Group, De Excellente Maatschap en het HagaZiekenhuis hebben een programma ontwikkeld voor de medisch managers van het HagaZiekenhuis. Inhoudelijk is het programma gebaseerd op twee pijlers: Value-Based Health Care middels o.a. Harvard Business School Cases en de drijfverenmethodiek van Management Drives gebaseerd op de theorie van dr. Clarence Graves.

Real-action learning in healthcare In cooperation with the Dutch Association of Medical Specialists (de Orde van Medisch Specialisten), The Decision Group developed a real-action learning program on hospital strategy. It is a 4-month program to educate medical staff, medical board and hospital board regarding the newest international insights on hospital strategy. Medical staff is educated on how to make strategic decisions within the strategic direction of the hospital overall. The program results in an actionable hospital strategy which is supported at all layers of the hospital.

Milestone Reports

  • The Value Agenda for The Netherlands 2017 (Report and working session, 2017) On May 11, 2017 key challenges for large-scale implementation of Value-Based Health Care (VBHC) were identified and discussed by twenty-five decision makers in health care from the Netherlands during a working session with Prof. Michael Porter. Prior to the working session, the components of Prof. Porter’s Value Agenda that contain the biggest challenges for the Netherlands were identified and a seventh component that proved to be key for VBHC implementation in the Netherlands was added: ‘Change culture and stimulate leadership’. The attendees and other leaders in health care identified over 60 key challenges in VBHC implementation that were categorized into the components of the Value Agenda. During an inspiring working session, an open and challenging discussion with Prof. Porter resulted in four key actions to accelerate VBHC implementation in the Netherlands.
  • Quality-based selection of hospitals for Transcatheter Heart Valve Intervention (Study, 2011) The study resulted in a description of an international standard for quality-based selection of hospitals. Immediate cause was a report of the Dutch Healthcare Inspection (IGZ) on the quality of hospitals regarding Transcatheter Heart Valve Interventions, a state-of-the-art treatment, which offers an alternative to surgical valve replacement. The study compares the results of the IGZ with international best-practices. It shows the relevance of outcome measures as prime indicators to measures the quality of healthcare delivery.
  • Changing Roles and Configurations of Hospitals (Study, 2008) This study shows that classic business theories do not apply to (Dutch) hospitals. A new method is developed that supports hospital portfolio decisions based on one overall joint hospital strategy. The method has been extensively tested among 20+ hospital board members and 50+ medical staff.
  • The future of the Dutch Healthcare System; Options and Roles of Health Insurers (Study, 2008) Recent changes in the Dutch Healthcare system give health insurers a more central role. One of the main results of this study is the identification of different roles for health insurers in the new healthcare system. Four archetypes of roles for health insurers have been developed. Health insurers can steer on six key drivers, depending on the role they choose to play in the healthcare system.